Abstract
Background
There are few data relating to the role of fatty score (FS) and modified fatty score (MFS) in ultrasonographic (US) examination on the diagnosis of nonalcoholic steatohepatitis (NASH) in patients undergoing bariatric surgery.
Methods
We investigated consecutive patients undergoing laparoscopic bariatric surgery with biopsy-proven nonalcoholic fatty liver disease. Patients with other liver diseases and significant alcohol consumption were excluded. Clinico-demographic and anthropometric data were collected before surgery. Each biopsy specimen was assessed by the same pathologist. Liver US examinations were performed by an independent and experienced sonographer before surgery. FS and MFS, determined by the US scoring system based on degrees of parenchymal echogenicity, far gain attenuation, gallbladder wall blurring, portal vein wall blurring and hepatic vein blurring, were used to assess the severity of fatty liver. US findings were correlated with histologic results.
Results
Totally 101 patients were enrolled. The mean BMI of the patients was 44.6 ±5.4 kg/m2. 29 patients (29%) were categorized with simple steatosis and 72 (71%) with NASH. FS and MFS were significantly correlated with the histological steatosis, fibrosis and the presence of NASH (P<0.001). A receiver operating characteristic curve identified the MFS of 2 as the best cut-off point for the prediction of NASH, yielding measures of sensitivity, specificity, positive predictive value, and accuracy for 72%, 86%, 93% and 76%, respectively. The positive likelihood ratio of 5.24 for MFS approximately doubled the post-test probability of NASH from 30% to 70%.
Conclusion
FS and MFS on US examination exhibit acceptable sensitivity and high specificity for the detection of the presence of NASH in morbidly obese patients and may aid in the selection of patients for closer follow-up or liver biopsy.
Similar content being viewed by others
References
Marchesini G, Brizi M, Morselli-Labate AM et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–5.
Mottin CC, Moretto M, Padoin AV et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005; 15: 788–93.
Stratopoulos C, Papakonstantinou A, Terzis I et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005; 15: 1154–60.
Matteoni C, Younossi Z, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–9.
Shalhub S, Parsee A, Gallagher SF et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004; 14: 54–9.
Piccinino F, Sagnelli E, Pasquale G et al. Complications following percutaneous liver biopsy: a multicenter retrospective study on 68276 biopsies. J Hepatol 1986;2: 165–73.
Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228–37.
Ong JP, Elaring H, Collantes R et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15: 310–5.
Boza C, Riquelme A, Ibanez L et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg 2005; 15: 1148–53.
Harnois F, Msika S, Sabate JM et al. Prevalence and predictive factors of nonalcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg 2006; 16: 183–8.
Yang PM, Huang GT, Lin JT et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver disease: a prospective study. J Formos Med Assoc 1988; 87: 966–77.
Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001; 21: 71–80.
Mottin CC, Moretto M, Pandoin AV et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14: 635–7.
Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg 2004; 14: 1165–70.
Lewis MC, Phillips ML, Slavotinek JP et al. Changes in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg 2006; 16: 697–701.
Saadeh S, Younossi ZM, Remer E et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745–50.
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31.
Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from plasma fasting glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
Banner BF, Savas L, Zivny J et al. Ubiguitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 2000; 114: 860–6.
Brunt EM, Janney CJ, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 1999; 94: 2467–74.
Promrat K, Lutchman G, Uwaifo GI et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004; 39: 188–96.
Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver steatohepatitis and the metabolic syndrome. Hepatology 2003; 37: 917–23.
Munoz SR, Bangdiwala SI. Interpretation of kappa and B statistic measures of agreement. J Appl Stat 1997; 24: 105–11.
Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. Am J Roentgenol 1985; 145: 753–5.
Di Lelia A, Cestari C, Lomazzi A et al. Cirrhosis: diagnosis with ultrasonographic study of the liver surface. Radiology 1989; 172: 389–92.
Sackett DL, Haynes BR, Guyatt GH et al. The interpretation of diagnostic data. In: Clinical Epidemiology: a Basic Science for Clinical Medicine. 2nd Edn. Boston, MA: Little, Brown, 1991: 69–152.
Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8: 97–106.
Abrams GA, Kunde SS, Lazenby AJ et al. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 2004; 40: 475–83.
Suchman AL, Dolan JG. Odds and likelihood ratios. In: Black ER, Bordley DR, Tape TG et al, eds. Diagnostic Strategies for Common Medical Problems. 2nd Edn. Philadelphia, PA: American College of Physicians 1999: 31–6.
Layer G, Zuna I, Lorenz A et al. Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition. J Clin Ultrasound 1991; 19: 193–201.
Kim SH, Lee JM, Kim JH et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images - initial experience. Radiology 2005; 234: 793–803.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liang, RJ., Wang, HH., Lee, WJ. et al. Diagnostic Value of Ultrasonographic Examination for Nonalcoholic Steatohepatitis in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery. OBES SURG 17, 45–56 (2007). https://doi.org/10.1007/s11695-007-9005-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-007-9005-6